Post-doctoral Fellow - Tumor Immunology

If you are interested in helping cancer patients by developing a new modality, the Neuro-Oncology Branch (NOB) at the National Cancer Institute (NCI) is a great place to take on this challenging task.  Immunotherapy has changed the paradigm of cancer treatment for the last 5 years, and now it is approved to treat more than 13 cancer types.  However, primary brain cancer has not received the benefit of the therapy.  The NOB’s Basic Immunology program works on the challenging goal of finding a way for immunotherapy to work against primary brain cancer.  The team closely collaborates with other teams, including NOB’s clinical team, to conduct multidisciplinary research with the potential for translational, clinical discoveries.

The Neuro-Oncology Branch (NOB), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking outstanding and highly motivated postdoctoral fellow candidates for a fellowship position in laboratory research on immunology of primary brain cancer.  The position is in the laboratory of NOB’s Basic Immunology program led by Masaki Terabe, Ph.D., whose goal is to develop novel immunotherapies for primary brain cancer patients.  The Basic Immunology program primarily focuses on the roles of unconventional T cells, such as CD1d-restricted NKT cells and MR1-restricted MAIT cells, and other types of T cells in the regulation of tumor immunity against primary brain cancer.  Candidates are expected to join a basic, translational, and collaborative research program.

The NOB also offers collaborative opportunities and resources through its various laboratory programs, encompassing areas of research in cell biology, genomics, and metabolomics, as well as its pre-clinical translational research program.  For more information on NOB, please visit: https://ccr.cancer.gov/Neuro-Oncology-Branch.

The successful candidate must have a Ph.D. and/or M.D. degree and less than four years of postdoctoral experience.  Proficiency in oral and written English is required.  Applicants with a strong background in immunology, preferably in cancer immunology, with bioinformatic skills are encouraged to apply.  A candidate should desirably be familiar with various types of immunological analysis.  Candidates may be U.S. citizens, U.S. permanent residents, or eligible for a visa that will enable work in the U.S.

Please email your curriculum vitae, statement of research interests, and three letters of reference to the attention of:  Masaki Terabe, Ph.D., Neuro-Oncology Branch, National Cancer Institute, 37 Convent Drive, Building 37, Room 1016A, Bethesda, MD 20892 at terabe@mail.nih.gov.

Candidates may be U.S. citizens, resident aliens, or nonresident aliens.  DHHS, NIH, the NCI and the NINDS are Equal Employment Opportunity and Affirmative Action employers and are dedicated to building a diverse community in its training and employment programs and encourages the application and nomination of qualified women, minorities, and individuals with disabilities.

About the NCI Center for Cancer Research

The Center for Cancer Research (CCR) is home to nearly 250 basic and clinical research groups located on two campuses just outside of Washington, D.C. CCR is part of the National Cancer Institute (NCI) and makes up the largest component of the research effort at the National Institutes of Health (NIH). Centrally supported by long-term funding and a culture of complete intellectual freedom, CCR scientists are able to pursue the most important and challenging problems in cancer research. We collaborate with academic and commercial partners and advocacy groups across the world in efforts to prevent, diagnose and treat cancer and HIV/AIDS. The CCR research portfolio covers the full spectrum of biological and biomedical research. Our work ranges from basic to translational and clinical, and our clinical trials are conducted in the NIH Clinical Center, the world’s largest hospital dedicated to clinical research that offers a robust infrastructure to support CCR’s patients on an estimated 250 open studies. The success of CCR is grounded in an exceptionally strong discovery research program that provides the foundation for the seamless translation of insights from bench to bedside.

Bethesda is one of the most highly educated communities in the United States and has a nationally renowned school system. The city is a thriving suburban center close to Washington, D.C., and home to many restaurants, retailers and a flourishing arts and entertainment district.